How to solve the big challenges of cell and gene therapy manufacturing
There has never been more investment and excitement around the cutting-edge medicine being developed under the umbrella of cell and…
sponsored
-
-
Podcast: Why the healthcare industry needs linked data
With GlobalData currently forecasting that the data and analytics market in pharma will reach $2.1bn by 2028, real-world data is…
-
Cell and gene therapy market outlook strong despite technical challenges
The cell and gene therapy (CGT) market is forecast to be worth almost $80bn by 2030, but issues must be…
-
How linked data can unlock the full potential of healthcare research
In today’s data-driven healthcare landscape, the ability to link disparate datasets is revolutionizing research and care delivery. As the global…
-
How ICH E6 (R3) is changing clinical trials
The latest ICH E6 (R3) guidelines could transform how clinical studies are built and operated. The updated ICH E6 (R3)…
-
Why global 3PL providers are essential to easing supply chain challenges
With tighter budgets, regulatory challenges, and uncertainty from tariffs, pharmaceutical companies are turning to third-party logistics (3PL) suppliers to deliver…
-
Scaling smart: how small pharma companies can build resilient supply chains
A robust supply chain is the backbone of stable growth, making it a critical area of concern for small pharma…
-
How to remain a top CDMO in ADC-led oncology
Contract development and manufacturing organisations (CDMOs) worldwide are facing a multitude of challenges, which are heightened considerably in oncology by…
-
CDMO insights podcast series: Our Experience is Your Strength | Episode #1 Formulation
The early stages of formulation development and analytical testing can be some of the most exciting phases of drug development,…
-
Five lessons from biopharma companies’ data transformation journeys
Author: Sebastian Wurst, Director, OpenData Strategy, Europe As global biopharmas expand into new markets, they introduce more systems to handle…
